Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myelodysplastic syndromes

R M Lowenthal1, K A Marsden

  • 1Clinical Haematology and Medical Oncology Unit, Royal Hobart Hospital, Australia.

International Journal of Hematology
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantifying the frequency and volume of urine deposition by grazing sheep using tri-axial accelerometers.

Animal : an international journal of animal bioscience·2021
Same author

EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

Chemotherapy-related cardiomyopathy: a neglected aspect of cancer survivorship.

Internal medicine journal·2014
Same author

Use of 'rainy day' autologous haemopoietic stem cells: a single-institution experience over 10 years.

Internal medicine journal·2014
Same author

Lymphoma studies by the Australasian Leukaemia and Lymphoma Group.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2013
Same author

Hypothesis. The importance of a histological diagnosis when diagnosing and treating advanced cancer. Famous patient recovery may not have been from metastatic disease.

Internal medicine journal·2011
Same journal

Cytarabine-based induction and oral maintenance therapy for a single system with single-site Langerhans cell histiocytosis.

International journal of hematology·2026
Same journal

Long-term treatment-free remission in CML after early dasatinib discontinuation due to interstitial pneumonitis.

International journal of hematology·2026
Same journal

Correction to: Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.

International journal of hematology·2026
Same journal

The efficacy of prophylactic tranexamic acid in patients with hematologic malignancy: a systematic review and meta-analysis.

International journal of hematology·2026
Same journal

Current status and challenges of TCR-T cell therapy for AML/MDS.

International journal of hematology·2026
Same journal

Efficacy and safety of maribavir in Japanese patients with post-transplant cytomegalovirus infections: a phase III study.

International journal of hematology·2026
See all related articles

Myelodysplastic syndromes (MDS) are clonal blood disorders causing low blood cell counts and poor outcomes, particularly in the elderly. Management is often supportive care, with limited effective treatments beyond bone marrow transplantation for younger patients.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders.
  • Common in the elderly, MDS leads to cytopenias and premature mortality.
  • Etiology is often unknown, but risk factors include chemotherapy and environmental mutagens.

Purpose of the Study:

  • To provide a comprehensive overview of myelodysplastic syndromes.
  • To discuss clinical presentation, diagnosis, and prognosis.
  • To review current and potential treatment strategies.

Main Methods:

  • Review of existing literature on MDS.
  • Analysis of clinical features, cytogenetics, and outcomes.
  • Evaluation of treatment efficacy and supportive care.

Related Experiment Videos

Main Results:

  • MDS presents with cytopenias and is characterized by hypercellular, disorganized bone marrow.
  • Non-random cytogenetic abnormalities, such as the 5q- and 7-syndromes, are diagnostic hallmarks.
  • Poor prognosis is associated with transformation to acute myeloid leukemia (AML) and complications of cytopenias.

Conclusions:

  • Effective treatments for MDS are limited, with allografting being curative only in select young patients.
  • Chemotherapy offers uncertain benefits, while cytokines like erythropoietin and GM-CSF show promise.
  • Supportive care remains the cornerstone of management for most MDS patients.